发明申请
US20110251244A1 Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient
有权
含有作为活性成分的PDE 4抑制剂和作为赋形剂的聚乙烯吡咯烷酮的口服剂型
- 专利标题: Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient
- 专利标题(中): 含有作为活性成分的PDE 4抑制剂和作为赋形剂的聚乙烯吡咯烷酮的口服剂型
-
申请号: US13008842申请日: 2011-01-18
-
公开(公告)号: US20110251244A1公开(公告)日: 2011-10-13
- 发明人: Rango Dietrich , Hartmut Ney , Klaus Eistetter
- 申请人: Rango Dietrich , Hartmut Ney , Klaus Eistetter
- 申请人地址: DE Konstanz
- 专利权人: NYCOMED GMBH
- 当前专利权人: NYCOMED GMBH
- 当前专利权人地址: DE Konstanz
- 优先权: DE10207160.8 20020220; EP02003811.3 20020220
- 主分类号: A61K31/44
- IPC分类号: A61K31/44 ; A61P11/00 ; A61P11/06
摘要:
Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.